Back to Newsroom

CombiMatrix to Present at Rodman & Renshaw Global Investment Conference

IRVINE, Calif., Sept. 2, 2015 (GLOBE NEWSWIRE) — CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal developmental disorders and pre-implantation genetic screening services, announces that President and Chief Executive Officer Mark McDonough will present a company overview at the Rodman & Renshaw 17th Annual Global Investment Conference on Wednesday, September 9, 2015, at 9:35 a.m. Eastern time (6:35 a.m. Pacific time). The conference is being held at the St. Regis Hotel in New York City.

A live webcast of the presentation will be available on the company’s website at and will be archived for 30 days.

Click here to read more